Gainers

• Broadwind, Inc. (NASDAQ:BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine manufacturer.
• Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) shares rose 45.2% to $0.6671 in pre-market trading after the company announced presentation of preclinical study highlighting anti-cancer activity of rencofilstat in combination with proteosome inhibitors.
• Party City Holdco Inc. (NYSE:PRTY) rose 37.5% to $0.6209 in pre-market trading. Party City Holdco shares jumped 118% on Tuesday following an Axios report suggesting The Franchise Group could be looking at acquiring the company.
• Biora Therapeutics, Inc. (NASDAQ:BIOR) shares rose 32.2% to $7.14 in pre-market trading after jumping 155% on Tuesday. Biora Therapeutics recently received pre-IND feedback from the FDA and issued an update on key programs for 2023.
• Jaguar Health, Inc. (NASDAQ:JAGX) rose 32.2% to $0.1335 in pre-market trading after gaining around 12% on Tuesday.
• Laser Photonics Corporation (NASDAQ:LASE) rose 29.3% to $3.27 in pre-market trading. Laser Photonics said on Jan. 9, that the company's board authorized initiation of share repurchase program to purchase up to 2 million shares of common stock.
• Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 22.5% to $2.54 in pre-market trading after adding more than 27% during regular market hours on Tuesday. According to a Wall Street Journal report citing people familiar with the matter, Bed Bath & Beyond has brought on consulting firm AlixPartners as its new restructuring advisor. The company reported a quarterly adjusted net loss of $3.65 per share, which missed estimates for a loss of $2.11 per share.
• Esports Entertainment Group, Inc. (NASDAQ:GMBL) rose 22.3% to $0.0999 in pre-market trading after gaining over 7% on Tuesday.
• AIM ImmunoTech Inc. (NYSE:AIM) shares rose 21.9% to $0.64 in pre-market trading after gaining 7% on Tuesday.
• ProKidney Corp. (NASDAQ:PROK) rose 19.9% to $9.20 in pre-market trading. ProKidney announced publication of trial design for Phase 2 multicenter clinical trial of REACT for late stage 4 diabetes-related chronic kidney disease.

Losers

• Cybin Inc. (NASDAQ:CYBN) fell 17.3% to $0.4650 in pre-market trading after gaining around 14% on Tuesday.
• FOXO Technologies Inc. (NASDAQ:FOXO) shares fell 12.7% to $0.2970 in pre-market trading after adding 6% on Tuesday.
• Argo Blockchain plc (NASDAQ:ARBK) fell 11.8% to $1.12 in pre-market trading after the company issued operational update for December 2022.
• Treasure Global Inc. (NASDAQ:TGL) fell 9.5% to $1.53 in pre-market. Treasure Global, on Tuesday, signed a MOU in Malaysia with Boost to discuss a new partnership..
• Lightning eMotors, Inc. (NYSE:ZEV) fell 9.1% to $0.4847 in pre-market trading. Lightning eMotors said it sees Q4 revenue of $4 million, versus analysts' estimates of $15.03 million.
• G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 8.8% to $3.28 in pre-market trading after dropping 18% on Tuesday.
• Apexigen, Inc. (NASDAQ:APGN) fell 8.6% to $1.71 in pre-market trading.
• Versus Systems Inc. (NASDAQ:VS) fell 8.1% to $0.6801 in pre-market trading after surging 22% on Tuesday.
• Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 7.5% to $0.0956 in pre-market trading after climbing 28% on Tuesday.
• Satixfy Communications Ltd. (NYSE:SATX) shares fell 7.1% to $6.45 in pre-market trading after gaining around 8% on Tuesday.